Our molecular studies suggest a complex mechanism of this nanoformulation on ischemia-related neuroinflammation in OHCs, including anti-inflammatory protein A20 stimulation and moderate attenuation of the NFκB signaling pathway. The gene discussed is NFKB1; the disease is ischemia.